Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Pierre Gueranger
Patient-Reported Treatment Satisfaction With Rivaroxaban for Stroke Prevention in Atrial Fibrillation. A French Observational Study, the SAFARI Study
PLoS ONE
Multidisciplinary
Related publications
Cost-Effectiveness of Rivaroxaban for the Prevention of Stroke in Patients With Non-Valvular Atrial Fibrillation – A Multinational Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Should Patient Characteristics Influence Target Anticoagulation Intensity for Stroke Prevention in Nonvalvular Atrial Fibrillation?: The ATRIA Study
Circulation. Cardiovascular quality and outcomes
Medicine
Cardiovascular Medicine
Cardiology
Stroke Prevention in Atrial Fibrillation
Journal of Atrial Fibrillation
Cardiovascular Medicine
Cardiology
Stroke Prevention in Atrial Fibrillation
International Journal of Arrhythmia
Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Primary and Secondary Prevention of Stroke and Systemic Embolism With Rivaroxaban in Patients With Non-Valvular Atrial Fibrillation
Heart and Vessels
Cardiovascular Medicine
Cardiology
Stroke Prevention in Atrial Fibrillation Trial
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Left Atrial Appendage Exclusion for Stroke Prevention in Atrial Fibrillation
Cardiology Research and Practice
Cardiovascular Medicine
Cardiology
Transient Ischemic Attacks in Patients With Atrial Fibrillation: Implications for Secondary Prevention: The European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III Trial
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
